Furthermore, 74.07% of ATCs harbored mutations in TSGs such as TP53, CDKN2A, PTEN, LATS1, LATS2, CTNNA2, TET1, and BRCA1 (Fig. 2b). This evidence concerns the gene LATS1 and Ehlers-Danlos syndrome, musculocontractural type.